Literature DB >> 7927758

Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytes with iron-transferrin.

R E Barnewall1, Y Rikihisa.   

Abstract

Ehrlichia chaffeensis is an obligate intracellular bacterium which infects cells of the macrophage/monocyte lineage. To test whether gamma interferon (IFN-gamma) inhibits infection of monocytes with E. chaffeensis, human peripheral blood monocytes were incubated with recombinant human IFN-gamma for 3 h and then exposed to E. chaffeensis. With 2,000 U of IFN-gamma per ml, maximal inhibition of infection by E. chaffeensis was observed. THP-1 cells, a human monocyte cell line, pretreated with phorbol myristic acetate or not pretreated, were incubated with various concentrations of IFN-gamma. Maximum inhibition was obtained at 1,000 U of IFN-gamma per ml with phorbol myristic acetate-treated THP-1 cells. However, nontreated cells did not achieve a similar level of anti-ehrlichial activity even with 10,000 U of IFN-gamma per ml. IFN-gamma given within 6 h postinfection was effective in inhibiting E. chaffeensis. Nitric oxide production was not demonstrated in the monocyte medium incubated with IFN-gamma and E. chaffeensis. None of the reactive oxygen intermediate scavengers tested blocked the IFN-gamma-induced anti-ehrlichial activity. Deferoxamine, an intracellular iron chelator, at 15 microM completely inhibited the survival of E. chaffeensis. Iron-saturated transferrin at 1.67 mg/ml completely reversed the IFN-gamma-induced ehrlichial killing. These results indicate that (i) E. chaffeensis is sensitive to intracytoplasmic iron depletion, (ii) E. chaffeensis is sensitive to IFN-gamma-induced killing, and (iii) the anti-ehrlichial activity induced in human monocytes by IFN-gamma is mediated by limitation of available cytoplasmic iron and is not due to the generation of reactive oxygen intermediates or nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927758      PMCID: PMC303190          DOI: 10.1128/iai.62.11.4804-4810.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  [Human infection by Ehrlichia canis in Spain?].

Authors:  A Guerrero; D B Fishbein; E Mesa; R Escudero
Journal:  Med Clin (Barc)       Date:  1991-02-16       Impact factor: 1.725

2.  First European case of ehrlichiosis.

Authors:  J D Morais; J E Dawson; C Greene; A R Filipe; L C Galhardas; F Bacellar
Journal:  Lancet       Date:  1991-09-07       Impact factor: 79.321

3.  Selective effects of protein C on activation of human monocytes by lipopolysaccharide, interferon-gamma, or PMA: modulation of effects on CD11b and CD14 but not CD25 or CD54 induction.

Authors:  S Grey; H Hau; H H Salem; W W Hancock
Journal:  Transplant Proc       Date:  1993-10       Impact factor: 1.066

4.  Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens.

Authors:  T F Byrd; M A Horwitz
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

5.  The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage.

Authors:  A Haziot; S Chen; E Ferrero; M G Low; R Silber; S M Goyert
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

6.  Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988.

Authors:  T R Eng; J R Harkess; D B Fishbein; J E Dawson; C N Greene; M A Redus; F T Satalowich
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

Review 7.  The tribe Ehrlichieae and ehrlichial diseases.

Authors:  Y Rikihisa
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Inhibition of Ehrlichia risticii infection in murine peritoneal macrophages by gamma interferon, a calcium ionophore, and concanavalin A.

Authors:  J Park; Y Rikihisa
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

9.  Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis.

Authors:  J E Dawson; B E Anderson; D B Fishbein; J L Sanchez; C S Goldsmith; K H Wilson; C W Duntley
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

10.  Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron.

Authors:  T F Byrd; M A Horwitz
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

View more
  50 in total

1.  Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1.

Authors:  R E Barnewall; N Ohashi; Y Rikihisa
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 2.  Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies.

Authors:  Jere W McBride; David H Walker
Journal:  Expert Rev Mol Med       Date:  2011-01-31       Impact factor: 5.600

Review 3.  Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen.

Authors:  David H Walker; Nahed Ismail; Juan P Olano; Jere W McBride; Xue-Jie Yu; Hui-Min Feng
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

4.  Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis.

Authors:  C D Paddock; J W Sumner; G M Shore; D C Bartley; R C Elie; J G McQuade; C R Martin; C S Goldsmith; J E Childs
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  Ixodes ovatus Ehrlichia exhibits unique ultrastructural characteristics in mammalian endothelial and tick-derived cells.

Authors:  Ulrike G Munderloh; David J Silverman; Katherine C MacNamara; Gilbert G Ahlstrand; Madhumouli Chatterjee; Gary M Winslow
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

6.  Absence of tumor necrosis factor alpha, interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor expression but presence of IL-1beta, IL-8, and IL-10 expression in human monocytes exposed to viable or killed Ehrlichia chaffeensis.

Authors:  E H Lee; Y Rikihisa
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

7.  Serum cytokine responses during acute human granulocytic ehrlichiosis.

Authors:  J S Dumler; E R Trigiani; J S Bakken; M E Aguero-Rosenfeld; G P Wormser
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

8.  Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.

Authors:  Wendy C Brown; Travis C McGuire; Waithaka Mwangi; Kimberly A Kegerreis; Henriette Macmillan; Harris A Lewin; Guy H Palmer
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

Review 9.  Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Vet Parasitol       Date:  2009-09-19       Impact factor: 2.738

10.  Neutrophils mediate immunopathology and negatively regulate protective immune responses during fatal bacterial infection-induced toxic shock.

Authors:  Qin Yang; Purnima Ghose; Nahed Ismail
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.